Financials Golden Sun Health Technology Group Limited
Equities
GSUN
KYG4013A1159
Miscellaneous Educational Service Providers
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.82 USD | +18.20% | +13.48% | +15.50% |
May. 07 | Top Midday Gainers | MT |
Apr. 17 | Golden Sun Gets Shareholder Approval for 1-for-10 Share Consolidation | MT |
Valuation
Fiscal Period: September | 2022 | 2023 |
---|---|---|
Capitalization 1 | 503.9 | 14.61 |
Enterprise Value (EV) 1 | 486.9 | 12.91 |
P/E ratio | -185 x | -2.59 x |
Yield | - | - |
Capitalization / Revenue | 46.6 x | 2.37 x |
EV / Revenue | 45 x | 2.1 x |
EV / EBITDA | -355 x | -2.16 x |
EV / FCF | 302,506,554 x | -1,877,975 x |
FCF Yield | 0% | -0% |
Price to Book | 57.3 x | 3.43 x |
Nbr of stocks (in thousands) | 1,836 | 1,836 |
Reference price 2 | 274.5 | 7.960 |
Announcement Date | 2/15/23 | 2/8/24 |
Income Statement Evolution (Annual data)
Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 15.17 | 13.96 | 15.03 | 10.81 | 6.156 |
EBITDA 1 | 5.218 | 2.081 | 2.095 | -1.371 | -5.984 |
EBIT 1 | 4.682 | 1.472 | 1.952 | -1.54 | -6.138 |
Operating Margin | 30.87% | 10.54% | 12.99% | -14.24% | -99.71% |
Earnings before Tax (EBT) 1 | 4.589 | 0.3117 | 1.966 | -1.764 | -5.643 |
Net income 1 | 3.366 | 0.042 | 1.979 | -2.139 | -5.786 |
Net margin | 22.19% | 0.3% | 13.17% | -19.78% | -94% |
EPS 2 | 6.983 | 0.0872 | 1.522 | -1.482 | -3.078 |
Free Cash Flow | - | 1.566 | -6.72 | 1.609 | -6.877 |
FCF margin | - | 11.22% | -44.72% | 14.88% | -111.72% |
FCF Conversion (EBITDA) | - | 75.24% | - | - | - |
FCF Conversion (Net income) | - | 3,727.2% | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 3/30/21 | 3/30/21 | 2/11/22 | 2/15/23 | 2/8/24 |
Balance Sheet Analysis
Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | 3.61 | 4.07 | 1.89 | - | - |
Net Cash position 1 | - | - | - | 17 | 1.7 |
Leverage (Debt/EBITDA) | 0.6927 x | 1.953 x | 0.9001 x | - | - |
Free Cash Flow | - | 1.57 | -6.72 | 1.61 | -6.88 |
ROE (net income / shareholders' equity) | - | -0.76% | -17.4% | -388% | -88.2% |
ROA (Net income/ Total Assets) | - | 5.83% | 10.1% | -6.4% | -17.9% |
Assets 1 | - | 0.721 | 19.53 | 33.41 | 32.35 |
Book Value Per Share 2 | -14.20 | -14.80 | -5.550 | 4.790 | 2.320 |
Cash Flow per Share 2 | 6.450 | 6.660 | 0.8800 | 11.10 | 3.430 |
Capex 1 | 0.59 | 1.69 | 0.09 | 0.17 | 0.25 |
Capex / Sales | 3.91% | 12.14% | 0.61% | 1.61% | 4.04% |
Announcement Date | 3/30/21 | 3/30/21 | 2/11/22 | 2/15/23 | 2/8/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+15.50% | 13.02M | |
+9.07% | 13.23B | |
-10.13% | 6.88B | |
+7.89% | 4.18B | |
+15.65% | 2.92B | |
+22.79% | 2.76B | |
+14.22% | 2.43B | |
+9.23% | 2.42B | |
+57.46% | 1.48B | |
+28.13% | 1.48B |
- Stock Market
- Equities
- GSUN Stock
- Financials Golden Sun Health Technology Group Limited